Wall Street Associates’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
GKFF
RO
AI
OCMI
HA
TAM
BIT
TAM
Wall Street Associates's ASPN Position: Q4 2016 in Review
Wall Street Associates reduced its Aspen Aerogels (ASPN) stake by 53% in Q4 2016, selling an estimated $1.52M and leaving 274,770 shares worth $1.14M. The position accounts for 0.75% of the portfolio, ranked #47.
Wall Street Associates first reported a position in ASPN in Q3 2015 and has held it in 6 quarters since. The position peaked at $3.49M in Q3 2016. 54 funds tracked by Wall St. Rank hold ASPN as of Q4 2016.
- Wall Street Associates held 274,770 shares of Aspen Aerogels worth $1.14M as of Q4 2016.
- Wall Street Associates sold 311,430 Aspen Aerogels shares in Q4 2016, an estimated $1.52M.
- Aspen Aerogels made up 0.75% of Wall Street Associates's portfolio in Q4 2016, its #47 holding.
- Wall Street Associates first reported a position in Aspen Aerogels in Q3 2015 and has held it in 6 quarters since.
- Wall Street Associates's Aspen Aerogels position peaked at $3.49M in Q3 2016.
- 54 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2016.
Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.